Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by rtftech16on Dec 09, 2017 8:08pm
72 Views
Post# 27125055

RE:RE:RE:This board

RE:RE:RE:This board Lol wow. You are absolutely stupid. They delevered from 35 to 28 billion in debt.. Porksniffer says its a screaming deal now boys and girls!! All that did was make people who were stupid in the first place for buying Valeant even dumber by buying now due to them only making their debt 28 billion. They are fundamantally toast. Their cash flow cannot support growth and their sales are declining. Its a facade and you are just another sheep. It's quite sad really. "Everyone buy Valeant now because their debt is only 28 billion, still more than their assets but its a steal buy buy buy!!". Get real. Same thing will happen when they dropped from 200+ level to where they are now. They will drop and drop and drop until they are a penny stock just like concordia. The stock price is the supply and demand of people buying or selling the shares. All that means is in the short term stupid people are buying. Does not represent the company's fundamentals or bottom line. Just like bitcoin lmao don't get me started. WOW your dumb hahah
Bullboard Posts